Variational AI will be at the CCG North American UGM & Conference in Montreal (June 23–26, 2026). Join Alex Perryman’s scientific presentation on June 25 on how MOE supported multiple drug discovery programs.

Learn More about Variational AI at CCG’s North American UGM & Conference 2026

Variational AI will be attending BIO International Convention 2026 in San Diego. We’ll be on-site for partnering meetings to connect with pharma and biotech teams interested in accelerating small-molecule programs with generative AI—especially where speed, novelty, and multi-parameter optimization are key. Our delegation will include: Handol Kim, CEO & Co-Founder Pete Guzzo, EVP & Head…

Learn More about Variational AI at BIO International Convention 2026

Variational AI will be at VivaTech 2026, taking place June 17–20 in Paris, France, as part of the Canadian delegation led by SCALE AI.

Learn More about Variational AI at VivaTech 2026

Variational AI will be taking part in the BC Tech Annual Member Summit on June 10, 2026. Handol will share how Variational AI applies generative AI for real impact, both within the organization and in its work with partners.

Learn More about Variational AI at the BC Tech Annual Member Summit

Variational AI is joining Web Summit Vancouver 2026, one of the world’s premier technology conferences, bringing together over 20,000 attendees, investors, and innovators from across the globe, right here in Vancouver. Handol Kim, Co-Founder and Chief Executive Officer of Variational AI, and Valentin Beuchillot, Senior Manager of BD & Marketing, will both be on the…

Learn More about Variational AI at WebSummit Vancouver 2026

Variational AI will participate in the upcoming Boston Pharmaceutical & Bioscience Society (PBSS) event, “Artificial Intelligence and Machine Learning: Shaping the Future of Therapeutic Drug Discovery, Development, and Manufacturing,” taking place April 28, 2026, in Cambridge, MA. This full-day symposium brings together leaders from biotechnology, academia, and pharmaceutical companies to discuss how artificial intelligence and…

Learn More about Variational AI to Present at PBSS Event on AI and ML in Drug Discovery

Variational AI will participate in MaRS Impact Health, a flagship health innovation event hosted by MaRS Discovery District that brings together entrepreneurs, investors, scientists, clinicians, and policymakers working to advance the future of healthcare. Meet with Variational AI If you are attending MaRS Impact Health and would like to connect with Variational AI to learn…

Learn More about Variational AI to Participate in the MaRS Impact Health Summit

Variational AI will participate in the Bloom Burton & Co. Healthcare Investor Conference (BBHIC), one of North America’s leading gatherings for healthcare investors and emerging life sciences companies. Meet with Variational AI Handol Kim, Co-Founder and Chief Executive Officer of Variational AI, will attend the conference to meet with investors and discuss the company’s approach…

Learn More about Variational AI to Participate in the Bloom Burton Healthcare Investor Conference

Variational AI will participate in ALL IN Talks West, an event bringing together researchers, industry leaders, builders, and decision-makers focused on the practical deployment of artificial intelligence systems in real-world environments. “From World-Class Research to Market Impact: Closing the Adoption Gap.” Handol Kim, Co-Founder and Chief Executive Officer of Variational AI, will speak on April…

Learn More about Variational AI to speak at ALL IN Talks West

Variational AI will participate in Drug Discovery Chemistry 2026, a premier conference for scientists focused on the discovery and optimization of small-molecule therapeutics. The event brings together medicinal, biophysical, and computational chemists from pharmaceutical companies, biotechnology organizations, and academic institutions to discuss new strategies and technologies for advancing drug discovery. Meet with Variational AI Brian…

Learn More about Variational AI at Drug Discovery Chemistry 2026

Variational AI is excited to participate in the inaugural AI Convergence: Small Molecule Discovery Summit in Boston, bringing together leaders at the intersection of AI/ML, computational chemistry, and medicinal chemistry. This is a great venue to compare notes on how generative approaches are being applied to real-world small-molecule design workflows (from hit expansion to multiparameter…

Learn More about Variational AI at AI Convergence: Small Molecule Discovery Summit 2026

Variational AI will be at Life Sciences BC’s 11th Annual Access to Innovation on February 25, 2026 in Vancouver. Connect with our team to discuss how generative AI is changing small-molecule discovery.

Learn More about Variational AI at LSBC’s 11th Annual Access to Innovation